Public Profile

Argenx

Argenx SE, a leading biotechnology company headquartered in the Netherlands, is at the forefront of developing innovative therapies for severe autoimmune diseases and cancer. Founded in 2008, Argenx has made significant strides in the industry, particularly with its proprietary antibody engineering platform, which enables the creation of unique therapeutic candidates. The company’s flagship product, efgartigimod, has garnered attention for its potential to transform treatment paradigms in conditions like myasthenia gravis. With a strong presence in Europe and North America, Argenx has established itself as a key player in the biopharmaceutical sector, recognised for its commitment to advancing patient care through cutting-edge science and strategic partnerships.

DitchCarbon Score

How does Argenx's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

26

Industry Average

Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

24

Industry Benchmark

Argenx's score of 26 is higher than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.

80%

Argenx's reported carbon emissions

In 2023, Argenx reported total carbon emissions of approximately 433,353,000 kg CO2e. This figure includes 378,000 kg CO2e from Scope 1 emissions, which are direct emissions from owned or controlled sources. Scope 2 emissions, related to the generation of purchased electricity, steam, heating, and cooling, amounted to about 189,000 kg CO2e (market-based). The majority of their emissions, approximately 432,786,000 kg CO2e, fall under Scope 3, which encompasses indirect emissions from the value chain. Notable contributors to Scope 3 emissions include purchased goods and services (about 378,956,000 kg CO2e) and business travel (approximately 5,328,000 kg CO2e). Currently, Argenx has not disclosed any specific reduction targets or initiatives aimed at decreasing their carbon footprint. As a company headquartered in the Netherlands, they are part of a growing industry trend towards transparency in emissions reporting and climate commitments. However, without defined reduction strategies, their future climate impact remains uncertain.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2023
Scope 1
378,000
Scope 2
189,000
Scope 3
432,786,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Argenx's primary industry is Research and development services (73), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Argenx is headquartered in NL, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Argenx is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Similar Organizations

NIOX Group Plc

GB
Health and social work services (85)
Updated 3 days ago

Ablynx NV

BE
Health and social work services (85)
Updated 27 days ago
DitchCarbon Score

Hikma Pharmaceuticals

GB
Health and social work services (85)
Updated 3 days ago

Vectura

GB
Medical, precision and optical instruments, watches and clocks (33)
Updated 3 days ago

MorphoSys

DE
Other business services (74)
Updated 3 days ago

Pharma Mar

ES
Medical, precision and optical instruments, watches and clocks (33)
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers